Skip to main content
Premium Trial:

Request an Annual Quote

Barry Greene, Robert Saltmarsh, Nick Venuto

Premium
Alnylam Pharmaceuticals has promoted Barry Greene from COO to president and COO, the firm announced last week. He will continue to report to CEO John Maraganore. Prior to Alnylam, Greene was general manager of oncology at Millennium Pharmaceuticals.
 

 
Robert Saltmarsh, vice president and chief financial officer at Nanogen, will retire from his position at the end of February 2008, the firm said last week. Saltmarsh will continue to consult with Nanogen through the end of next year as needed.
 
Nick Venuto, executive director of finance, has been named as Saltmarsh's successor. Venuto has been responsible for financial operations and reporting for the last four years.

Filed under

The Scan

Pig Organ Transplants Considered

The Wall Street Journal reports that the US Food and Drug Administration may soon allow clinical trials that involve transplanting pig organs into humans.

'Poo-Bank' Proposal

Harvard Medical School researchers suggest people should bank stool samples when they are young to transplant when they later develop age-related diseases.

Spurred to Develop Again

New Scientist reports that researchers may have uncovered why about 60 percent of in vitro fertilization embryos stop developing.

Science Papers Examine Breast Milk Cell Populations, Cerebral Cortex Cellular Diversity, Micronesia Population History

In Science this week: unique cell populations found within breast milk, 100 transcriptionally distinct cell populations uncovered in the cerebral cortex, and more.